This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: The Cleveland Clinic Foundation. Active years: 2008-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008-2012
Title: Keiji Kamohara: Innovator in Tissue Engineering
Introduction
Keiji Kamohara is a notable inventor based in Mayfield Heights, OH (US). He has made significant contributions to the field of tissue engineering, particularly through his innovative patents. With a total of 3 patents, Kamohara's work focuses on developing synthetic materials for medical applications.
Latest Patents
One of Kamohara's latest patents is titled "Hydroxyphenyl cross-linked macromolecular network and applications thereof." This invention provides a dihydroxyphenyl cross-linked macromolecular network that is particularly useful in artificial tissue and tissue engineering applications. The synthetic macromolecular network is designed for a variety of tissue types, including artificial cartilage, vocal cord material, vitreous material, soft tissue material, and mitral valve material. The network is composed of tyramine-substituted and cross-linked hyaluronan molecules, with cross-linking achieved via peroxidase-mediated dityramine linkages that can be performed in vivo. The dityramine bonds create a stable, coherent hyaluronan-based hydrogel with desired physical properties.
Career Highlights
Kamohara is associated with the Cleveland Clinic Foundation, where he continues to advance his research and innovations in tissue engineering. His work has the potential to significantly impact the medical field by providing new solutions for tissue repair and regeneration.
Collaborations
Some of Kamohara's coworkers include Anthony Calabro and Aniq B Darr, who contribute to his research efforts and innovations.
Conclusion
Keiji Kamohara is a prominent inventor whose work in tissue engineering is paving the way for advancements in synthetic materials for medical applications. His innovative patents reflect his commitment to improving healthcare through technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
